Gregory Carven is the founder of Scholar Rock. Based in Cambridge, Massachusetts, United States.
Gregory Carven, PhD, is a leader at Scholar Rock, a biotechnology company focused on discovering and developing drugs that selectively target supracellular activation of growth factors in the disease microenvironment. The company's programs target specific growth factors in diseases like fibrosis, musculoskeletal diseases, immuno-oncology, and autoimmune diseases. Carven was recognized as an "Inventor of the Year" for his work on Keytruda® while at Merck and Company.
Full founder directory · Investor directory · Company funding database · Fundraising library